2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2019 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 3
Sole participant: 1
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2021 | 0 | 4.014.435 | 303.173 | 1 | ||
2020 | 0 | 3.989.713 | 303.173 | 1 | ||
2019 | 224.934 | 4.147.223 | 528.106 | 1 | 1 |
Total number of partners: 35
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 35
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2021-03-01 | Deconstructing the evolution of metastasis | Evomet | participant | 4.014.435 | 15 |
2020-12-01 | Validation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate students | VAGABOND | participant | 3.989.713 | 12 |
2019-12-01 | Short linear interaction motifs as specificity determinants in the ubiquitin system – discovery, mechanisms and therapeutic opportunities | UBIMOTIF | participant | 4.147.223 | 11 |
2019-05-01 | The rise and fall of metastatic clones under immune attack | EVOMET | coordinator | 224.934 | 1 |